Inspire Medical Systems (INSP) Net Cash Flow (QoQ) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Inspire Medical Systems | 1.17 Bn | 889.44 Mn | 176.91 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 24.17% |
| Dec 31, 2025 | -233.67% |
| Sep 30, 2025 | -89.04% |
| Jun 30, 2025 | 155.14% |
| Mar 31, 2025 | -3,524.25% |
| Dec 31, 2024 | 106.87% |
| Sep 30, 2024 | -423.03% |
| Jun 30, 2024 | 227.48% |
| Mar 31, 2024 | 93.15% |
| Dec 31, 2023 | -5.45% |
| Sep 30, 2023 | -650.15% |
| Jun 30, 2023 | 4,566.85% |
| Mar 31, 2023 | -97.74% |
| Dec 31, 2022 | -89.80% |
| Sep 30, 2022 | 1,480.95% |
| Jun 30, 2022 | -50.00% |
| Mar 31, 2022 | -361.14% |
| Dec 31, 2021 | -87.29% |
| Sep 30, 2021 | 681.14% |
| Jun 30, 2021 | 29.14% |
| Mar 31, 2021 | -169.21% |
| Dec 31, 2020 | 136.30% |
| Sep 30, 2020 | -124.07% |
| Jun 30, 2020 | 153.72% |
| Mar 31, 2020 | 311.56% |
| Dec 31, 2019 | -673.78% |
| Sep 30, 2019 | 93.58% |
| Jun 30, 2019 | -1,190.04% |
| Mar 31, 2019 | -93.45% |
| Dec 31, 2018 | 174.25% |
| Sep 30, 2018 | -186.30% |
| Jun 30, 2018 | 4,950.46% |
| Mar 31, 2018 | 139.25% |
| Dec 31, 2017 | 29.90% |
| Sep 30, 2017 | -97.01% |
| Jun 30, 2017 | -120.36% |